Article Text

PDF

Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
  1. M Piazza,
  2. R Orlando,
  3. G Tosone,
  4. D Tiseo,
  5. M C Conte,
  6. F Minervini,
  7. G Santoro,
  8. F Scordino,
  9. D Vitale
  1. Department of Infectious Diseases, II Medical School, University of Naples, Italy.

    Abstract

    In a study of 87 patients with chronic hepatitis C, 12 months' treatment with interferon alfa-2b at a dose of 6 million units (MU) three times per week seemed to be more effective than treatment with 3 MU three times a week for two months plus 1.5 MU three times a week for 10 months in increasing the percentage of long term responders. The percentage of patients in whom alanine amino-transferase activities returned to normal was highest in the 6 MU group, as was the percentage of responders who sustained this normal activity after treatment. Side effects were moderate and self-limited in most patients.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.